Report on the Iowa Department of Public Safety for the year ended June 30, 2012

Report on the Iowa Department of Public Safety for the year ended June 30, 2012

La depuración del personal del Museo Arqueológico de Barcelona y del Servicio de Investigaciones Arqueológicas después de la Guerra Civil (1939-1941)

Al finalizar la Guerra Civil española (1936-1939), el personal del Museu d' Arqueologia y de la Secció d'Excavacions i Arqueologia del Servei del Patrimoni Artístic, Historic i Científic (SPAHC) de la suprimida Generalitat de Catalunya fue sometido a depuración por parte del Juzgado Militar Especial de Funcionarios de la Diputación Provincial de Barcelona. La llegada como nuevo director de Martín Almagro Basch, en substitución del exiliado Pere Bosch Gimpera, y el resultado de la reorganización subsiguiente marcaron el desarrollo de la investigación arqueológica en Cataluña hasta finales de la década de 1960.

Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.

BACKGROUND: The preservation of globe integrity has always been a major concern during the treatment of retinoblastoma for fear of extraocular or metastatic spread. Intravitreal chemotherapy has been attempted as a desperate salvage therapy only for eyes with refractory retinoblastoma. Published data on the safety and efficacy of this route are, however, limited. METHODS: A modified technique of intravitreal injection in eyes with retinoblastoma is described. All children with retinoblastoma who received one or more intravitreal injections using this technique were retrospectively reviewed concerning ocular complications of the injection procedure as well as clinical or histopathological evidence of tumour spread. RESULTS: 30 eyes of 30 children with retinoblastoma received a total of 135 intravitreal injections, with a median follw-up duration of 13.5 months. No extraocular spread was seen on clinical follow-up in any patients and there was no tumour contamination of the retrieved entry sites histopathologically analysed among the five enucleated eyes. No significant ocular side effects were observed except transient localised vitreous haemorrhage (3/135). CONCLUSION: This technique is potentially safe and effective at a low cost and may play a promising role, especially in the treatment of recurrent and/or resistant vitreous disease in retinoblastoma, as an alternative to enucleation and/or external beam radiotherapy. However, this treatment should not replace the primary standard of care of retinoblastoma and should not be considered in group E eyes. Its application should be approved by an ophthalmological-oncological team and it should be performed by an experienced eye surgeon in a tertiary referral centre after careful selection of a tumour-free injection site.

Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort.

BACKGROUND: There is limited data available regarding safety profile of artemisinins in early pregnancy. They are, therefore, not recommended by WHO as a first-line treatment for malaria in first trimester due to associated embryo-foetal toxicity in animal studies. The study assessed birth outcome among pregnant women inadvertently exposed to artemether-lumefantrine (AL) during first trimester in comparison to those of women exposed to other anti-malarial drugs or no drug at all during the same period of pregnancy. METHODS: Pregnant women with gestational age <20 weeks were recruited from Maternal Health clinics or from monthly house visits (demographic surveillance), and followed prospectively until delivery. RESULTS: 2167 pregnant women were recruited and 1783 (82.3%) completed the study until delivery. 319 (17.9%) used anti-malarials in first trimester, of whom 172 (53.9%) used (AL), 78 (24.4%) quinine, 66 (20.7%) sulphadoxine-pyrimethamine (SP) and 11 (3.4%) amodiaquine. Quinine exposure in first trimester was associated with an increased risk of miscarriage/stillbirth (OR 2.5; 1.3-5.1) and premature birth (OR 2.6; 1.3-5.3) as opposed to AL with (OR 1.4; 0.8-2.5) for miscarriage/stillbirth and (OR 0.9; 0.5-1.8) for preterm birth. Congenital anomalies were identified in 4 exposure groups namely AL only (1/164[0.6%]), quinine only (1/70[1.4%]), SP (2/66[3.0%]), and non-anti-malarial exposure group (19/1464[1.3%]). CONCLUSION: Exposure to AL in first trimester was more common than to any other anti-malarial drugs. Quinine exposure was associated with adverse pregnancy outcomes which was not the case following other anti-malarial intake. Since AL and quinine were used according to their availability rather than to disease severity, it is likely that the effect observed was related to the drug and not to the disease itself. Even with this caveat, a change of policy from quinine to AL for the treatment of uncomplicated malaria during the whole pregnancy period could be already envisaged.

Elaboración de un video sobre calidad, seguridad y medio ambiente en la Unidad de Laboratorios Docentes (ULD) de la Facultad de Farmacia de la Universidad de Barcelona

La Unidad de Laboratorios Docentes (ULD) de la Facultad de Farmacia (UB) ha implantado un sistema de gestión de la calidad (SGC) que permite transmitir al estudiante una formación adicional con el objetivo de mejorar sus competencias transversales (siguiendo las directrices del Espacio Europeo de Educación Superior, EEES). Además, en el curso académico 06-07, se instauraron las Buenas Prácticas Ambientales (BPAL) para disponer de un sistema de gestión que incorporase los criterios de calidad, medioambiente y seguridad (sistema de gestión integrada, SGI). Durante el presente curso académico se ha procedido a la grabación y edición de un video sobre calidad, seguridad y medioambiente en la ULD con el objetivo de mejorar la formación transversal de los estudiantes facilitando la integración de los conocimientos y habilidades profesionales. De esta forma, al salir del entorno universitario, los licenciados y graduados de la Facultad de Farmacia dispondrán de un valor añadido en su formación, mejorando así sus competencias para el desarrollo de su futura profesión. En el video se muestra la manera de trabajar correctamente según las normas de calidad, seguridad y medioambiente recogidas además en un tríptico que se entrega a los estudiantes al acceder por primera vez a un laboratorio de prácticas. El video se difundirá a través de la página web de la ULD, de la videoteca de la UB, del canal You Tube Canal UB, así como de las asignaturas que lo soliciten (sirviendo de soporte para el personal docente).

Iowa Department of Public Safety Performance Report, FY2004

Agency Performance Report

Iowa Department of Public Safety Performance Report, FY2005

Agency Performance Report

Iowa Department of Public Safety Performance Report, FY2006

Agency Performance Report

Iowa Department of Public Safety Performance Report, FY2007

Agency Performance Report

Iowa Department of Public Safety Performance Report, FY2008

Agency Performance Report

Iowa Department of Public Safety Performance Report, FY2011

Agency Performance Report

Iowa Department of Public Safety Performance Report, FY2010

Agency Performance Report

Influenza vaccination in immunocompromised patients: efficacy and safety.

Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance of the influenza virus infection, as well as the immunogenicity and safety of the influenza vaccine in HIV‑infected individuals, solid-organ and stem-cell transplant recipients and patients receiving biological agents. Epidemiological data produced during the 2009 influenza pandemic have confirmed that immunocompromised patients remain at high risk of influenza-associated complications, namely viral and bacterial pneumonia, hospitalization and even death. The immunogenicity of the influenza vaccine is overall reduced in immunocompromised patients, although a significant clinical protection from influenza is expected to be obtained with vaccination. Influenza vaccination is safe in immunocompromised patients. The efficacy of novel strategies to improve the immunogenicity to the vaccine, such as the use of adjuvanted vaccines, boosting doses and intradermal vaccination, needs to be validated in appropriately powered clinical trials.

Iowa Department of Public Safety Performance Report, FY2012

Agency Performance Report

Iowa Department of Public Safety Performance Report, FY2013

Agency Performance Report